Growth Metrics

Cme (CME) Non-Current Deferred Tax Liability (2016 - 2025)

Cme (CME) has disclosed Non-Current Deferred Tax Liability for 13 consecutive years, with $5.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 1.69% to $5.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $5.2 billion, a 1.69% decrease, with the full-year FY2024 number at $5.2 billion, down 1.52% from a year prior.
  • Non-Current Deferred Tax Liability was $5.2 billion for Q3 2025 at Cme, roughly flat from $5.2 billion in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.4 billion in Q2 2021 to a low of $5.2 billion in Q3 2025.
  • A 5-year average of $5.3 billion and a median of $5.3 billion in 2023 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: fell 4.45% in 2021, then increased 0.18% in 2022.
  • Cme's Non-Current Deferred Tax Liability stood at $5.4 billion in 2021, then fell by 0.54% to $5.4 billion in 2022, then fell by 0.62% to $5.3 billion in 2023, then fell by 1.52% to $5.2 billion in 2024, then decreased by 0.51% to $5.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Non-Current Deferred Tax Liability are $5.2 billion (Q3 2025), $5.2 billion (Q2 2025), and $5.2 billion (Q1 2025).